Owing to the lack of significant α-synuclein pathology or of major amyloid-β or Tau deposition in DLB and any significant cell loss in the primary visual cortex in DLB, whole genome microarrays were used to determine the changes in gene expression associated with hypoperfusion and hypometabolism. This evidence concerns the gene SNCA and Lewy body dementia.